bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.298
-0.005 (-1.68%)
At close: Nov 21, 2024, 4:00 PM
0.299
+0.002 (0.50%)
After-hours: Nov 21, 2024, 6:04 PM EST
bluebird bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 58 | 266 | 574 | 700 | 2,872 | 4,855 | |
| Market Cap Growth | -69.02% | -53.64% | -18.08% | -75.61% | -40.85% | -10.51% | |
| Enterprise Value | 363 | 395 | 711 | -89 | 1,629 | 3,645 | |
| Last Close Price | 0.30 | 1.38 | 6.92 | 9.99 | 28.01 | 56.80 | |
| PS Ratio | 1.00 | 9.02 | 159.50 | 191.25 | - | - | |
| PB Ratio | -17.41 | 1.37 | 4.27 | 1.87 | 2.12 | 3.78 | |
| P/TBV Ratio | - | 1.49 | 4.63 | 1.90 | 2.14 | 3.86 | |
| EV/Sales Ratio | 6.84 | 13.40 | 197.64 | - | - | - | |
| Debt / Equity Ratio | -64.83 | 1.71 | 2.73 | 0.24 | 0.05 | 0.15 | |
| Asset Turnover | 0.10 | 0.05 | 0.01 | 0.00 | - | - | |
| Quick Ratio | 0.29 | 1.17 | 1.24 | 2.02 | 3.35 | 5.01 | |
| Current Ratio | 0.51 | 1.41 | 1.30 | 2.20 | 5.97 | 5.15 | |
| Return on Equity (ROE) | -270.20% | -128.87% | -90.58% | -65.07% | -42.50% | -35.02% | |
| Return on Assets (ROA) | -36.91% | -25.68% | -26.35% | -29.53% | -19.92% | -17.72% | |
| Return on Capital (ROIC) | -44.45% | -29.68% | -31.76% | -37.22% | -24.14% | -20.02% | |
| Earnings Yield | -499.99% | -79.67% | -40.15% | -116.99% | -21.54% | -16.26% | |
| FCF Yield | -456.44% | -89.94% | -56.55% | -92.83% | -17.39% | -13.09% | |
| Buyback Yield / Dilution | -72.23% | -39.75% | -14.04% | -10.83% | -12.66% | -6.07% | |
| Total Shareholder Return | -72.23% | -39.75% | -14.04% | -10.83% | -12.66% | -6.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.